Drug
oral metronidazole
oral metronidazole is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
1
25%
Ph phase_2
2
50%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)
Trials by Status
completed250%
not_yet_recruiting125%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH
NCT07566754
recruitingphase_1
Vaginal Microbiota Transplant
NCT04046900
completednot_applicable
Topical vs Oral Metronidazole After Benign Anorectal Surgery
NCT05038605
completedphase_2
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
NCT01361048
Clinical Trials (4)
Showing 4 of 4 trials
NCT07566754Phase 2
MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH
NCT04046900Phase 1
Vaginal Microbiota Transplant
NCT05038605Not Applicable
Topical vs Oral Metronidazole After Benign Anorectal Surgery
NCT01361048Phase 2
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4